Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowHematopoietic Stem CellsTransplantation ConditioningBone Marrow CellsHematologic NeoplasmsBusulfanTransplantation, AutologousTissue DonorsImmunosuppressive AgentsWhole-Body IrradiationCytomegalovirus InfectionsTreatment OutcomeGraft SurvivalHematopoiesisLeukemiaTransplantation ChimeraBone and BonesAnemia, AplasticRetrospective StudiesHistocompatibility TestingKidney TransplantationStem Cell TransplantationHistocompatibilityLiver TransplantationBone Marrow PurgingMice, Inbred C57BLStem CellsAntiviral AgentsCyclophosphamideGraft RejectionTransplantation, IsogeneicRecurrenceTime FactorsAntigens, CD34Colony-Forming Units AssayLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraCombined Modality TherapyBone Marrow DiseasesCell DifferentiationHepatic Veno-Occlusive DiseaseTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionTransplantationLeukemia, MyeloidHeart TransplantationImmunosuppressionHematopoietic Stem Cell MobilizationAcute DiseaseFlow CytometryT-LymphocytesHematologic DiseasesHLA AntigensLymphocyte DepletionSurvival AnalysisBone Marrow ExaminationMyelodysplastic SyndromesCell LineageLymphoma, Non-HodgkinCyclosporineCells, CulturedLung TransplantationLeukocyte TransfusionSevere Combined ImmunodeficiencyBone RemodelingBone Marrow NeoplasmsChimeraGranulocyte Colony-Stimulating FactorPeripheral Blood Stem Cell TransplantationCord Blood Stem Cell TransplantationGraft vs Host ReactionHematopoietic SystemSurvival RateGraft vs Leukemia EffectImmunocompromised HostFollow-Up StudiesLymphocyte TransfusionChimerismCell SeparationOpportunistic InfectionsAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaMice, KnockoutFetal BloodTransplantsGraft vs Tumor EffectSpleenDisease-Free SurvivalCell TransplantationBlood CellsOrgan TransplantationGranulocytesMelphalanFatal Outcome